RxDoctor Payments Data

Michael Severson, MD

Pain Medicine · Meridian, IDNPI 1205827904

Payments from drug & device makers

What this record shows

13 manufacturers reported payments, led by Boston Scientific at 37.1% of the total. Reporting peaked in 2019 at $1,900 and has fallen 91.9% since, to $153 in 2025. That places this record below the midpoint for pain medicine clinicians in ID, where the typical reported total is $4,838.

$4,565in general payments, 2019–2025

Across 67 payments — averaging $68.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Relievant Medsystems, Inc.$1K
  • SPR Therapeutics, Inc$445
  • Stimwave Technologies Incorporated$370
  • Avanos Medical$193
  • Nalu Medical, Inc.$132
  • plus $309 from 7 others

What the payments were for

  • Travel & lodging$1,99744%
  • Food & beverage$2,56856%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,565 in reported general payments places this provider in the 45th percentile of 32 pain medicine providers in Idaho.

See all pain medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$103,752
Medicare patients
462
Services billed
1,086

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl31$2,387
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen52$1,048
Gabapentin76$896
Oxycodone Hcl20$240
Duloxetine Hcl27$209
Pregabalin16$161
Morphine Sulfate ErMorphine Sulfate11$105
Diclofenac Sodium13$77
Celecoxib13$60

Paid to pharmacies, not to this prescriber.

Other pain medicine in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →